Cargando…
Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
BACKGROUND: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depend highly on stage and WHO-grade. Both the WHO73 and the WHO04 grading systems show some intra- and interobserver variability. The current pilot study investigates which histopathological features are...
Autores principales: | Kvikstad, Vebjørn, Mangrud, Ok Målfrid, Gudlaugsson, Einar, Dalen, Ingvild, Espeland, Hans, Baak, Jan P. A., Janssen, Emiel A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694469/ https://www.ncbi.nlm.nih.gov/pubmed/31412916 http://dx.doi.org/10.1186/s13000-019-0868-3 |
Ejemplares similares
-
Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder
por: Mangrud, Ok Målfrid, et al.
Publicado: (2014) -
Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
por: Lillesand, Melinda, et al.
Publicado: (2020) -
Quantitative Analysis of Tumor-Associated Mast Cells in Recurrent and Non-recurrent Urothelial Bladder Cancer in Stage pTa and pT1
por: Popov, Hristo, et al.
Publicado: (2021) -
Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004) -
Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?
por: Dangi, Anuj Deep, et al.
Publicado: (2018)